TD Waterhouse Canada Inc. Sells 4,097 Shares of Astera Labs, Inc. $ALAB

TD Waterhouse Canada Inc. lowered its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 24.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 12,337 shares of the company’s stock after selling 4,097 shares during the period. TD Waterhouse Canada Inc.’s holdings in Astera Labs were worth $2,052,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ALAB. Vanguard Group Inc. lifted its holdings in Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after buying an additional 1,693,918 shares during the period. Amundi lifted its holdings in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the period. Rafferty Asset Management LLC acquired a new position in Astera Labs during the 3rd quarter worth about $209,599,000. BNP Paribas Financial Markets lifted its holdings in Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares during the period. Finally, Voloridge Investment Management LLC acquired a new position in Astera Labs during the 3rd quarter worth about $131,539,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the transaction, the chief operating officer directly owned 1,531,301 shares of the company’s stock, valued at $189,590,376.81. The trade was a 5.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,064,888 shares of company stock worth $150,764,723 over the last three months. Insiders own 12.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ALAB shares. Loop Capital started coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. UBS Group started coverage on Astera Labs in a report on Tuesday. They set a “neutral” rating and a $180.00 target price on the stock. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $250.00 target price on shares of Astera Labs in a report on Tuesday. Citigroup started coverage on Astera Labs in a report on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price on the stock. Finally, Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Fifteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $199.74.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Analyst price‑target upgrades and “buy” calls (RBC, Loop Capital and others) have pushed optimism around ALAB’s multi‑year revenue runway; recent coverage and PT upgrades helped drive buying interest. Read More.
• Positive Sentiment: Large cloud/AI deal flow (notably the Anthropic/Amazon cluster) is being read as incremental demand for Astera’s CXL/PCIe retimers and fabric products — a direct revenue lever if hyperscalers convert commitments into orders. Read More.
• Positive Sentiment: Recent results show rapid top‑line growth and an EPS beat (record revenue and raised Q1 guidance), supporting the case that Astera’s products are gaining adoption in AI racks. Read More.
• Positive Sentiment: Institutional demand: large fund buys (e.g., BlackRock and others increasing positions) and renewed hedge‑fund interest are amplifying momentum. Read More.
• Neutral Sentiment: UBS started coverage with a Neutral rating and a $180 target — the research acknowledges strong AI networking fundamentals but places a conservative near‑term view on valuation vs. upside expectations. Read More.
• Neutral Sentiment: Upcoming Q1 earnings (early May) are an obvious near‑term catalyst: results and customer commentary can either validate the momentum or inject volatility depending on order visibility and guidance. Read More.
• Negative Sentiment: Heavy insider selling (CEO and other insiders have sold sizable blocks in recent weeks; trades were done under 10b5‑1 plans) creates a headline risk and can sap momentum even if pre‑arranged. Read More.
• Negative Sentiment: High valuation and volatility: ALAB trades at a rich multiple (high P/E) and is subject to momentum swings — downside can amplify quickly if analyst sentiment or hyperscaler order visibility cools. Read More.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $197.54 on Friday. The company has a market capitalization of $33.83 billion, a price-to-earnings ratio of 161.92, a P/E/G ratio of 3.82 and a beta of 1.78. The business’s 50-day moving average is $132.20 and its 200-day moving average is $154.08. Astera Labs, Inc. has a 1 year low of $61.18 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm’s revenue was up 91.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts anticipate that Astera Labs, Inc. will post 1.48 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.